GSK2849330
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2849330, covering 2019-02-21 to 2019-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors [Phase 1]